Skip to content
lifestyle.sli.mg
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XORTX Therapeutics Inc.
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
September 10, 2026
XORTX Announces Termination and Postponement of Investor Relations Program
August 28, 2026
XORTX Announces Director Resignation
July 31, 2026
XORTX Appoints New Director
July 29, 2026
XORTX Announces Closing of US$5 Million Public Offering
May 22, 2026
XORTX Announces US$5 Million Public Offering
May 21, 2026
XORTX Meets Nasdaq Continued Listing Requirements
April 21, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
April 14, 2026
XORTX Confirms Effective Date of Share Consolidation
April 2, 2026
XORTX Announces Results of Annual and Special Meeting of Shareholders
March 27, 2026
1
2
Next Page
→